249 related articles for article (PubMed ID: 21631389)
1. Development and characterization of rifampicin loaded floating microspheres.
Goyal P; Gill S; Gupta UD; Rath G; Narang RK; Goyal AK
Artif Cells Blood Substit Immobil Biotechnol; 2011 Oct; 39(5):330-4. PubMed ID: 21631389
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable anionic acrylic resin based hollow microspheres of moderately water soluble drug rosiglitazone maleate: preparation and in vitro characterization.
Rane BR; Gujarathi NA; Patel JK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1460-9. PubMed ID: 22356275
[TBL] [Abstract][Full Text] [Related]
3. Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosis.
Samad A; Sultana Y; Khar RK; Chuttani K; Mishra AK
J Microencapsul; 2009 Feb; 26(1):83-9. PubMed ID: 18608799
[TBL] [Abstract][Full Text] [Related]
4. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Singh V; Chaudhary AK
Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
Pandey R; Khuller GK
J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
[TBL] [Abstract][Full Text] [Related]
7. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin.
Makino K; Nakajima T; Shikamura M; Ito F; Ando S; Kochi C; Inagawa H; Soma G; Terada H
Colloids Surf B Biointerfaces; 2004 Jul; 36(1):35-42. PubMed ID: 15261021
[TBL] [Abstract][Full Text] [Related]
8. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
[TBL] [Abstract][Full Text] [Related]
9. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
Li GY; Zhong M; Zhou ZD; Zhong YD; Ding P; Huang Y
Int J Biol Macromol; 2011 Dec; 49(5):970-8. PubMed ID: 21889529
[TBL] [Abstract][Full Text] [Related]
10. Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.
Srivastava AK; Ridhurkar DN; Wadhwa S
Acta Pharm; 2005 Sep; 55(3):277-85. PubMed ID: 16375838
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
12. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
O'Hara P; Hickey AJ
Pharm Res; 2000 Aug; 17(8):955-61. PubMed ID: 11028941
[TBL] [Abstract][Full Text] [Related]
13. Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.
Hu LD; Xing QB; Shang C; Liu W; Liu C; Luo ZL; Xu HX
Pharmazie; 2010 Jul; 65(7):477-80. PubMed ID: 20662314
[TBL] [Abstract][Full Text] [Related]
14. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
Jain SK; Awasthi AM; Jain NK; Agrawal GP
J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748
[TBL] [Abstract][Full Text] [Related]
15. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
16. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
19. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
[TBL] [Abstract][Full Text] [Related]
20. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
Preda M; Leucuta SE
J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
